RDAC · Rising Dragon Acquisition Corp.

The thesis

Rising Dragon Acquisition Corp. is a blank-check company with no operating business. Its only merger ended on 30 October 2026, and the shares closed at $11.20 on 9 November 2026, 2.8% above the $10.90 per-share trust value in its latest 10-Q, for 30 June 2026. The case for the shares now depends on a new merger agreement. Without one, a liquidation or redemption pays out roughly the trust value, which monthly deposits and interest have lifted since June toward the current price.

The mutual termination of the HZJL Cayman Limited agreement, announced 3 November 2026, carried no termination fee for either side, according to the company's 8-K. The company said it will keep looking for a target within the time its articles allow. Its current deadline is 15 November 2026, set by promissory notes totalling $55,637.41 that were issued on 30 October 2026 to fund the trust and extend the deadline.

The story of a merger with HZJL is dead: the agreement was terminated effective 30 October 2026. Since then the shares have traded on hopes for a new target. TipRanks reported a 117.5% premarket jump on 3 November 2026, the day the termination was announced. The rating is low. The shares trade close to the trust value with a 14-day relative strength index (RSI) of 91.2, and no new target has been named.

Bullish and bearish views on Rising Dragon Acquisition Corp.

The bull case on Rising Dragon Acquisition Corp. (RDAC), in brief: Trust value puts a floor near $10.90. The bear case: Little room above trust value.

Bull case

• Trust value puts a floor near $10.90. The 10-Q for the quarter to 30 June 2026 lists 1,685,982 public shares subject to possible redemption at $10.90 each. Monthly extension deposits of $0.033 a share and trust interest have added to that since, so a redemption pays out near or above that figure.
• The sponsor keeps paying to extend. On 30 October 2026, after the merger had already ended, the company issued $55,637.41 of promissory notes to fund the trust and move the deadline to 15 November 2026. A sponsor that funds extensions after a deal collapses is signalling that it intends to find another deal.
• Deadline room runs to late 2027. The May 2026 proxy (DEF 14A filed 8 May 2026) proposed up to 15 monthly extensions, out to 15 October 2026 plus 12 months, i.e. 15 October 2027. Monthly extensions have continued since. That leaves time to sign a new target.
• Deal news has moved the shares sharply. The shares rose more than 400% intraday to $21.72 on 29 April 2026, the day after the extension proxy was filed, according to Stockti. They also jumped on the 3 November 2026 termination news.

Bear case

• Little room above trust value. The $11.20 close on 9 November 2026 is 2.8% above the $10.90 per-share redemption value at 30 June 2026, before the deposits made since. If the company liquidates, holders receive about the trust value, so the shares have little to gain without a new deal.
• The Nasdaq listing is at risk. Nasdaq notified the company on 19 August 2026 that the market value of its listed securities was below the $35 million minimum (Rule 5550(b)(2)). It must close at or above $35 million for 10 consecutive business days by 16 February 2027 or face a delisting notice (8-K, 20 August 2026).
• No target is named. The 3 November 2026 termination release gives no reason for the break-up and names no replacement. A new target needs due diligence, a signed agreement and a proxy, which takes months.
• The rally looks stretched. Adjusted daily closes show a 76.4% gain over three months to 9 November 2026 and an RSI of 91.2. Both are levels at which past spikes in this stock, including April 2026, have given back much of their gain.
• The public float is small and uncertain. Redemptions have shrunk the share count since the October 2024 initial public offering (IPO) of 5,750,000 units. Holders redeemed 2,515,673 shares on 29 May 2026 and 3 June 2026, leaving 1,685,982 public shares at 30 June 2026 (10-Q). A float this small can produce large moves on little volume in either direction.

Price setup

The last close was $11.20 on 9 November 2026. That is 45.4% below the 52-week closing high of $20.51, set in the April 2026 spike on the extension proxy. The 14-day RSI of 91.2 is extreme. The three-month gain of 76.4% came mostly from the termination news in early November.

The level that matters most is the $10.90 per-share trust value reported at 30 June 2026, which monthly deposits have raised since. Above it, the shares carry a premium for an expected new deal. A sustained close below it would mean the market is pricing in a liquidation, or doubting that the full trust will be paid out.

Catalysts, next 30 days

• 15 November 2026: The current business-combination deadline. The sponsor must fund another monthly extension, or the company moves toward liquidation.
• ~16 November 2026, est.: The third-quarter 2026 report (Form 10-Q) is due. It should show the trust balance and redeemable share count after the 2026 extension vote. The 2025 third-quarter 10-Q was filed on 5 November 2025.
• ~15 December 2026, est.: The next monthly extension date, if the sponsor funds the 15 November 2026 extension.
• Unscheduled: A letter of intent or merger agreement with a new target. This is the event the premium over trust value depends on.

What would change the view

The case breaks on liquidation: any filing in which the company says it will not extend past 15 November 2026, or that it intends to wind up and redeem public shares, caps the shares near the trust value. A 10-Q showing a per-share trust value well below $10.90, or a missed extension deposit, would point the same way. A daily close below $10.90, the last reported per-share trust value, would show the market has dropped the new-deal premium.

A signed agreement with a named target and a credible valuation would strengthen the case. So would a 10-Q showing the trust intact at a per-share value close to the current price.

What it trades with

RDAC trades on its own trust and deal news, so it has little in common with the operating companies in the M&A and special-situations group (SLN, SGRY, ADT, HELE, SKYA). That group has cooled since early November. The cooling matters less here than the 15 November 2026 deadline and any new-target filing. The shares have no meaningful link to the S&P 500. That cuts both ways for relative performance: a broad market rally does not lift the shares, and a liquidation would leave them lagging the index.